Interpace Biosciences, Inc. (IDXG)
6.025
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Interpace Biosciences Cash from Operations (Quarterly) : 0.098M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.098M |
| March 31, 2026 | 0.283M |
| December 31, 2025 | 2.138M |
| September 30, 2025 | 1.938M |
| June 30, 2025 | 0.52M |
| March 31, 2025 | 1.235M |
| December 31, 2024 | 1.184M |
| September 30, 2024 | 2.116M |
| June 30, 2024 | 1.404M |
| March 31, 2024 | -0.058M |
| December 31, 2023 | 1.14M |
| September 30, 2023 | 1.105M |
| June 30, 2023 | 0.411M |
| March 31, 2023 | 1.133M |
| December 31, 2022 | -0.276M |
| September 30, 2022 | -3.244M |
| June 30, 2022 | -2.918M |
| March 31, 2022 | -1.254M |
| December 31, 2021 | -1.218M |
| September 30, 2021 | -0.694M |
| June 30, 2021 | -1.924M |
| March 31, 2021 | -5.006M |
| December 31, 2020 | -1.584M |
| September 30, 2020 | -5.722M |
| June 30, 2020 | 0.449M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.122M |
| December 31, 2019 | -6.401M |
| September 30, 2019 | -4.771M |
| June 30, 2019 | -4.825M |
| March 31, 2019 | -2.96M |
| December 31, 2018 | -1.873M |
| September 30, 2018 | -1.773M |
| June 30, 2018 | -2.533M |
| March 31, 2018 | -2.494M |
| December 31, 2017 | -2.379M |
| September 30, 2017 | -4.209M |
| June 30, 2017 | -4.526M |
| March 31, 2017 | -4.149M |
| December 31, 2016 | -0.99M |
| September 30, 2016 | -1.346M |
| June 30, 2016 | -1.301M |
| March 31, 2016 | -3.97M |
| December 31, 2015 | |
| September 30, 2015 | -5.396M |
| June 30, 2015 | -2.523M |
| March 31, 2015 | -5.617M |
| December 31, 2014 | -8.412M |
| September 30, 2014 | 0.322M |
| June 30, 2014 | -1.825M |
| March 31, 2014 | -6.463M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Medical Marijuana, Inc. | 0.5945M |
| Acro Biomedical Co. Ltd. | -0.0105M |
| Stella Diagnostics, Inc. | -0.9776M |
| ZeroStack Corp. | 1.384M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.057M |
| Free Cash Flow | 4.104M |
| Free Cash Flow Per Share (Quarterly) | 0.0074 |
| Free Cash Flow to Equity (Quarterly) | 0.147M |
| Free Cash Flow to Firm (Quarterly) | 0.041M |
| Free Cash Flow Yield | 12.29% |